Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

47.18
-0.9900-2.06%
Post-market: 47.500.3200+0.68%19:58 EDT
Volume:7.90M
Turnover:376.02M
Market Cap:95.43B
PE:15.09
High:48.23
Open:48.16
Low:47.13
Close:48.17
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:2.14
T/O Rate:0.41%
Dividend:1.79
Dividend Rate:3.80%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.10
PE(LYR):12.63

Loading ...

GSK’s NEBULA-1 MASH Cirrhosis Trial: A New Catalyst in Metabolic Liver Disease

TIPRANKS
·
Aug 06

GSK's New Drug Launches Will be Key to 2027 Outlook

Dow Jones
·
Aug 04

Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 04

GlaxoSmithKline (GSK) Receives a Sell from Barclays

TIPRANKS
·
Aug 04

TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 03

Bernstein Sticks to Their Buy Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Aug 03

GSK price target raised to 2,000 GBp from 1,950 GBp at Deutsche Bank

TIPRANKS
·
Jul 31

GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum

TIPRANKS
·
Jul 31

GSK Slips Thursday, Underperforms Market

Dow Jones
·
Jul 31

GSK Supply Chain President Registers Sale of Ordinary Shares

TIPRANKS
·
Jul 30

GSK's ViiV Healthcare Highlights New Long-Acting Injectable Data on Cabenuva in HIV Treatment

MT Newswires Live
·
Jul 29

Cabenuva demonstrates superiority to daily oral therapy in adolescents with HIV

TIPRANKS
·
Jul 29

GSK: Hold Rating Reaffirmed as Near-Term Strength Offsets Long-Term Uncertainties; 2,350p Price Target Maintained

TIPRANKS
·
Jul 29

GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals

Benzinga Earnings
·
Jul 29

GSK Rises Tuesday, Outperforms Market

Dow Jones
·
Jul 29

GSK Licensor's Late-Stage China Study for Risvutatug Rezetecan in Bone Cancer Meets Primary Endpoint

MT Newswires Live
·
Jul 28

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 28

GSK Heading in Right Direction, but Investors Might Stay on Sidelines

Dow Jones
·
Jul 28

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

Dow Jones
·
Jul 28

Stock Track | GSK Soars 5.31% in Pre-Market on Strong Q2 Earnings Beat and Positive Oncology Pipeline Updates

Stock Track
·
Jul 28